Guru Ownership Trend
Guru Analysis for Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $54.36 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $13.21 M net outflow during the quarter.
Recent activity highlights Stanley Druckenmiller who opened a new position. Conversely, Cliff Asness reduced exposure by 45.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Cogent Biosciences, Inc. (COGT)
Major holders include Steven Cohen ($25.31 M), Renaissance Technologies (RenTech) ($22.69 M), Stanley Druckenmiller ($7.08 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.03 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $13.21 M, with 2 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited COGT. The total reported sell value was $21.78 M.
Yes, 1 managers opened new positions in COGT, and 1 increased their existing holdings. The total reported buy value was $8.56 M.